NCT07514338: Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease
- State
- Under way
- Phase
- Phase 2
- People
- 140 planned
- Started
- 12 Jun 2026
- Primary completion
- 31 Mar 2029
- Arms
- Open label extension
- Results
- None posted
- 7 Apr 2026: Trial registered
- 12 Jun 2026: Trial started